CAS 21282-90-6
:3(2H)-Pyridazinone, 6-(4-aminophenyl)-4,5-dihydro-
Description:
3(2H)-Pyridazinone, 6-(4-aminophenyl)-4,5-dihydro- is a chemical compound characterized by its pyridazinone core structure, which features a six-membered ring containing two nitrogen atoms. This compound has a 4-aminophenyl substituent, indicating the presence of an amino group attached to a phenyl ring, which can influence its reactivity and biological activity. The dihydro designation suggests that the compound has two hydrogen atoms added to the pyridazinone ring, resulting in a saturated structure that may affect its stability and solubility. Typically, compounds of this nature may exhibit various pharmacological properties, making them of interest in medicinal chemistry. The presence of both nitrogen and amino functional groups can enhance interactions with biological targets, potentially leading to applications in drug development. Additionally, the molecular structure can influence its physical properties, such as melting point, boiling point, and solubility in different solvents. Overall, this compound represents a class of heterocyclic compounds that are significant in various chemical and pharmaceutical contexts.
Formula:C10H11N3O
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
6-(4-Aminophenyl)-2,3,4,5-tetrahydropyridazin-3-one
CAS:<p>Levosimendan is a drug that is used in the treatment of congestive heart failure. It is an orally active, positive inotropic agent with vasodilator properties. Levosimendan has been shown to be effective for the treatment of chronic heart failure and can be used as a substitute for dobutamine. This drug also has a structural similarity to phthalazinone, which has been shown to have clinical use in the treatment of acute myocardial infarction.</p>Formula:C10H11N3OPurity:Min. 95%Molecular weight:189.21 g/mol
